Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

44
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
44
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Practical Comparison of Two- and Three-Phase Bearingless Permanent Magnet Slice Motors for Blood Pumps.

Actuators·2026
Same author

Utility of Right Ventricular Mass Ratios in Recipients With Pulmonary Hypertension: A United Network for Organ-Sharing Database Analysis.

Clinical transplantation·2026
Same author

Ideal Body Weight Ratio for Donor-to-Recipient Size Matching in Heart Transplantation.

Clinical transplantation·2025
Same author

Heart Allograft Utilization Rates Following Donation After Circulatory Death Compared to Donation After Brain Death in the Ideal Heart Donor.

Clinical transplantation·2025
Same author

Microaxial Support as a Bridge to Repair in Post-Myocardial Infarction Ventricular Septal Rupture: A Systematic Review and Patient-Level Analysis.

Artificial organs·2025
Same author

Report on the 30th Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS).

Artificial organs·2025

相关实验视频

Updated: Sep 14, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

儿童心力衰竭的双重血系统的激活机制设计.

Thomas C Palazzolo1, Giselle C Matlis1, Ethan Pastor1

  • 1BioCirc Research Laboratory, School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pennsylvania, USA.

Artificial organs
|July 24, 2025
PubMed
概括

这项研究引入了一种用于儿科心力衰竭的新型双血腹腔辅助装置 (VAD),其具有较低的血液损伤潜力和有效的现场激活,可改善患者的治疗结果.

关键词:
儿科血 儿科血是一种血.儿科循环支持的儿童循环支持.小儿整体人工心脏腹腔室辅助器件可以帮助心室.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K

相关实验视频

Last Updated: Sep 14, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K

科学领域:

  • 生物医学工程 生物医学工程
  • 儿童心脏病学 儿童心脏病学
  • 医疗器械开发 医疗器械开发

背景情况:

  • 儿科末期心力衰竭 (HF) 提出了独特的治疗挑战.
  • 目前的机械循环支持 (MCS) 设备显示,与成人相比,儿童的结果不够理想.
  • 需要针对儿科患者量身定制的先进MCS解决方案.

研究的目的:

  • 为儿科患者开发和评估一种新型的双重血心室辅助装置 (VAD).
  • 创建一个单一设备解决方案,在各种儿科年龄范围内提供有效的支持.
  • 根据心脏需求的增加,为二次设计一个创新的激活机制.

主要方法:

  • 利用虚拟研究来改进基于功能和解剖学约束的激活机制设计.
  • 进行了代的设计改进,以达到性能目标.
  • 进行了体外功能,液压和溶血流循环测试,以评估设备性能和血液兼容性.

主要成果:

  • 开发的原型展示了有效的和可重复的in-situ执行.
  • 该设备在生理压力和流量下提供了无泄漏的支持.
  • 血液溶解测试表明血液损伤的可能性很低.

结论:

  • 这项研究验证了新型VAD的提议激活机制.
  • 这些发现支持德雷克塞尔双龙VAD继续用于儿科应用的翻译开发.